124 related articles for article (PubMed ID: 22264592)
21. Arterial complications associated with cardiac catheterization in pediatric patients with a previous history of Kawasaki disease.
Gurofsky RC; Sabharwal T; Manlhiot C; Redington AN; Benson LN; Chahal N; McCrindle BW
Catheter Cardiovasc Interv; 2009 May; 73(6):809-13. PubMed ID: 19180654
[TBL] [Abstract][Full Text] [Related]
22. Long-term prognostic impact of dobutamine stress echocardiography in patients with Kawasaki disease and coronary artery lesions: a 15-year follow-up study.
Noto N; Kamiyama H; Karasawa K; Ayusawa M; Sumitomo N; Okada T; Takahashi S
J Am Coll Cardiol; 2014 Feb; 63(4):337-44. PubMed ID: 24140657
[TBL] [Abstract][Full Text] [Related]
23. Prediction of the risk of coronary arterial lesions in Kawasaki disease by serum 25-hydroxyvitamin D3.
Chen YL; Wang JL; Li WQ
Eur J Pediatr; 2014 Nov; 173(11):1467-71. PubMed ID: 24889335
[TBL] [Abstract][Full Text] [Related]
24. Study on the relationship between mean platelet volume and platelet distribution width with coronary artery lesion in children with Kawasaki disease.
Liu R; Gao F; Huo J; Yi Q
Platelets; 2012; 23(1):11-6. PubMed ID: 21675937
[TBL] [Abstract][Full Text] [Related]
25. Expression of nuclear factor -κBp65 in mononuclear cells in Kawasaki disease and its relation to coronary artery lesions.
Yin W; Wang X; Ding Y; Peng H; Liu YL; Wang RG; Yang YL; Xiong JH; Kang SX
Indian J Pediatr; 2011 Nov; 78(11):1378-82. PubMed ID: 21688043
[TBL] [Abstract][Full Text] [Related]
26. Arterial haemodynamics in patients after repair of tetralogy of Fallot: influence on left ventricular after load and aortic dilatation.
Senzaki H; Iwamoto Y; Ishido H; Matsunaga T; Taketazu M; Kobayashi T; Asano H; Katogi T; Kyo S
Heart; 2008 Jan; 94(1):70-4. PubMed ID: 17540688
[TBL] [Abstract][Full Text] [Related]
27. Linear shadows inside coronary arterial lesions on two-dimensional echocardiograhpy in Kawasaki disease patients.
Hamaoka A; Niboshi A; Ozawa S; Tamiya H; Ito H; Shiraishi I; Itoi T; Hamaoka K
J Cardiol; 2009 Jun; 53(3):349-54. PubMed ID: 19477375
[TBL] [Abstract][Full Text] [Related]
28. Impaired endothelial function in epicardial coronary arteries after Kawasaki disease.
Mitani Y; Okuda Y; Shimpo H; Uchida F; Hamanaka K; Aoki K; Sakurai M
Circulation; 1997 Jul; 96(2):454-61. PubMed ID: 9244212
[TBL] [Abstract][Full Text] [Related]
29. Combination of fecal calprotectin and initial coronary dimensions to predict coronary artery lesions persistence in Kawasaki disease.
Fabi M; Filice E; Andreozzi L; Mattesini BE; Rizzello A; Palleri D; Dajti E; Zagari RM; Lanari M
Sci Rep; 2022 May; 12(1):8640. PubMed ID: 35606405
[TBL] [Abstract][Full Text] [Related]
30. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
[TBL] [Abstract][Full Text] [Related]
31. Red Blood Cell Distribution Width as a Predictive Marker for Coronary Artery Lesions in Patients with Kawasaki Disease.
Ming L; Cao HL; Li Q; Yu G
Pediatr Cardiol; 2021 Oct; 42(7):1496-1503. PubMed ID: 34036412
[TBL] [Abstract][Full Text] [Related]
32. Noncoronary inflammation in Kawasaki disease is associated with abnormal myocardial deformation in the acute phase.
Gaur L; Waloff K; Schiller O; Sable CA; Frank LH
J Am Soc Echocardiogr; 2014 Dec; 27(12):1329-35. PubMed ID: 25479899
[TBL] [Abstract][Full Text] [Related]
33. [Matrix metalloproteinase-1 expression in the circulation of patients with Kawasaki disease and its role in the pathogenesis of coronary artery lesions].
Yang SW; Wang DW; Li J; Qin YM; Wang FM; Cao LM; Zhang LF; Hu Z
Zhonghua Er Ke Za Zhi; 2005 Aug; 43(8):612-5. PubMed ID: 16191276
[TBL] [Abstract][Full Text] [Related]
34. [Changes of P-selectin and E-selectin in children with Kawasaki disease].
Qiu Y; Wu J; Fang XY; Lin Z; Wu BY; Cai RY; Xu XY; Zheng H
Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):688-92. PubMed ID: 15482673
[TBL] [Abstract][Full Text] [Related]
35. [The role of endogenous vascular elastase in coronary artery reconstruction in Kawasaki disease].
Liu YL; Wang XM; Li Y; Shi K; Guo YH; Yang YF; Chen TT
Zhongguo Dang Dai Er Ke Za Zhi; 2014 Apr; 16(4):389-92. PubMed ID: 24750836
[TBL] [Abstract][Full Text] [Related]
36. In vivo plaque composition and morphology in coronary artery lesions in adolescents and young adults long after Kawasaki disease: a virtual histology-intravascular ultrasound study.
Mitani Y; Ohashi H; Sawada H; Ikeyama Y; Hayakawa H; Takabayashi S; Maruyama K; Shimpo H; Komada Y
Circulation; 2009 Jun; 119(21):2829-36. PubMed ID: 19451352
[TBL] [Abstract][Full Text] [Related]
37. High sensitivity C-reactive protein and endothelial function in Chilean patients with history of Kawasaki disease.
Borzutzky A; Gutiérrez M; Talesnik E; Godoy I; Kraus J; Hoyos R; Arnaiz P; Acevedo M
Clin Rheumatol; 2008 Jul; 27(7):845-50. PubMed ID: 18071779
[TBL] [Abstract][Full Text] [Related]
38. The expression and significance of serum caveolin-1 in patients with Kawasaki disease.
Zhu F; Huang J; Wang X; Li P; Yan Y; Zheng Y; He Y; Wu T; Ren Y; Wu R
Chin J Physiol; 2020; 63(2):90-94. PubMed ID: 32341235
[TBL] [Abstract][Full Text] [Related]
39. Soluble LR11 is a novel biomarker for vascular lesions late after Kawasaki disease.
Watanabe K; Suzuki H; Jiang M; Haniu H; Numano F; Hoshina S; Saitoh A; Uchiyama M; Bujo H
Atherosclerosis; 2016 Mar; 246():94-7. PubMed ID: 26761773
[TBL] [Abstract][Full Text] [Related]
40. Prospective follow-up cardiac evaluation of children with Kawasaki disease in Northern India using the Japanese echocardiography criteria.
Kothur K; Singh S; Sharma Y; Mittal BR
J Cardiol; 2007 Nov; 50(5):299-307. PubMed ID: 18044459
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
